Suppr超能文献

新生儿不同中心静脉导管的血流感染发生率:一项描述性队列研究。

Bloodstream Infection Incidence of Different Central Venous Catheters in Neonates: A Descriptive Cohort Study.

作者信息

Dubbink-Verheij Gerdina H, Bekker Vincent, Pelsma Iris C M, van Zwet Erik W, Smits-Wintjens Vivianne E H J, Steggerda Sylke J, Te Pas Arjan B, Lopriore Enrico

机构信息

Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Leiden, Netherlands.

Department of Statistics, Leiden University Medical Center, Leiden, Netherlands.

出版信息

Front Pediatr. 2017 Jun 20;5:142. doi: 10.3389/fped.2017.00142. eCollection 2017.

Abstract

UNLABELLED

Central venous catheters (CVCs) in neonates are associated with a risk of central line-associated bloodstream infections (CLABSI). Most reports on the incidence of CLABSI in neonates focus on umbilical venous catheters (UVCs) and peripherally inserted central catheters (PICCs). We evaluated the incidence and risk factors for CLABSI in a cohort of neonates with femoral venous catheters (FVCs), UVCs, and PICCs, with a gestational age ≥34 weeks born between January 1, 2006 and June 30, 2013. We included 2,986 neonates with a total of 656 catheters. The CLABSI incidence rate varied from 12.3 per 1,000 catheter-days in FVCs to 10.6 per 1,000 catheter-days in UVCs and 5.3 per 1,000 catheter-days in PICCs. In a Kaplan-Meier survival analysis, we did not find a difference in CLABSI risk between the catheter types ( = 0.29). The following factors were independently associated with an increased risk of CLABSI: parenteral nutrition [hazard ratio (HR) 2.60, 95% confidence interval (CI) 1.25-5.41], male gender (HR 2.63, 95% CI 1.17-5.90), and higher birth weight (HR 1.04, 95% CI 1.002-1.09), whereas antibiotic treatment at birth (HR 0.25, 95% CI 0.12-0.52) was associated with a decreased risk.

CONCLUSION

In our cohort, we did not find a difference between the CLABSI incidence in FVCs, PICCs, and UVCs. Occurrence of CLABSI is associated with parenteral nutrition, male gender, and higher birth weight. Antibiotic treatment at birth was associated with a decreased risk of CLABSI.

摘要

未标注

新生儿中心静脉导管(CVC)与中心静脉导管相关血流感染(CLABSI)风险相关。大多数关于新生儿CLABSI发病率的报告集中在脐静脉导管(UVC)和外周静脉穿刺中心静脉导管(PICC)。我们评估了2006年1月1日至2013年6月30日期间出生、胎龄≥34周、使用股静脉导管(FVC)、UVC和PICC的新生儿队列中CLABSI的发病率及危险因素。我们纳入了2986名新生儿,共使用了656根导管。CLABSI发病率从FVC的每1000导管日12.3例到UVC的每1000导管日10.6例以及PICC的每1000导管日5.3例不等。在Kaplan-Meier生存分析中,我们未发现不同类型导管之间CLABSI风险存在差异(P = 0.29)。以下因素与CLABSI风险增加独立相关:肠外营养[风险比(HR)2.60,95%置信区间(CI)1.25 - 5.41]、男性(HR 2.63,95%CI 1.17 - 5.90)以及较高出生体重(HR 1.04,95%CI 1.002 - 1.09),而出生时使用抗生素治疗(HR 0.25,95%CI 0.12 - 0.52)与风险降低相关。

结论

在我们的队列中,我们未发现FVC、PICC和UVC的CLABSI发病率存在差异。CLABSI的发生与肠外营养、男性及较高出生体重相关。出生时使用抗生素治疗与CLABSI风险降低相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验